Arrhythmia Detection After MI (Acute Myocardial Infarction)
This study is looking at whether using an implantable cardiac monitor (ICM) can help doctors better manage patients who have recently had a heart attack (acute myocardial infarction or AMI). An ICM is a small device placed under your skin to monitor your heart rhythm. Researchers want to see if using an ICM changes how doctors treat patients and how quickly heart rhythm problems are found and treated. You might be able to join if you are an adult (18 or older) who recently had a heart attack and do not have other implanted heart devices. The study aims to enroll 200 participants. The study's success will be measured by changes in patient management and the time it takes to diagnose and treat heart rhythm issues within 90 days after your heart attack.
- Study design
- This is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 200 participants.
- What's involved
- You would either receive routine monitoring with clinic visits or have an ICM implanted through a small incision within 21 days of your heart attack.
- Compensation
- Not stated in the trial record.
- Follow-up
- Changes to patient management and time to diagnosis/treatment of arrhythmia will be measured at 90 days post-AMI.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Arrhythmia Detection After MI
At a glance
Conditions
NCT05073419
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvaniastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Samir F Saba, MD · PRINCIPAL_INVESTIGATOR · University of Pittsburgh Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Changes to patient management90 days post AMI
Incidence (frequency) of cardiac arrhythmias (bradyarrhythmia, tachyarrhythmia, pause, etc…) that lead to actionable treatment change
- Time to diagnosis and/or treatment of cardiac arrhythmia90 days post AMI
days post randomization